Category: basic life sciences retractions

Eighth Voinnet paper retracted — this one from Science

Olivier Voinnet
Olivier Voinnet

A high-profile plant scientist who has been racking up corrections and retractions at a steady clip has had another paper — this one from Science — retracted.

The retraction, of a paper that had been previously corrected, is the eighth for Olivier Voinnet. According to the notice, the correction did not address all the figure problems with the paper, which “cannot be considered the result of mistakes.”

Here’s the notice in full: Continue reading Eighth Voinnet paper retracted — this one from Science

Cancer researcher earns 5th retraction after misconduct finding

oncoimmunologyA cancer researcher has logged her fifth retraction following an investigation that concluded she had committed scientific misconduct.

We’ve previously reported on four retractions of papers by Stephanie Watkins, a researcher at Loyola Medicine. The previously issued notices — in The Journal of Clinical Investigation and Cancer Research — note that an investigation committee appointed by the National Institutes of Health (NIH) found Watkins to be solely responsible for the misconduct, with none of the co-authors aware of it.

The editor of OncoImmunology previously informed us that the journal was investigating another one of Watkins’ papers; the journal has now pulled that paper, citing “fabrication and falsification of data” in the original studies referenced in the paper.

Here’s the retraction notice, published online earlier this year: Continue reading Cancer researcher earns 5th retraction after misconduct finding

Retraction notice for GMO paper updated to include fraud

fns2015012717103119Earlier this year, a nutrition journal retracted an article about the potential dangers of eating food containing genetically modified organisms (GMOs), noting the paper contained a duplicated image.

At the time, news outlets in Italy were reporting accusations that the last author, Federico Infascelli, an animal nutrition researcher at the University of Naples, had falsified some of his research.

Food and Nutrition Sciences has now updated its initial notice, saying the paper was pulled for data fabrication. In addition, Infascelli is no longer listed on its editorial board – he is included on an archived link to the editorial board from March 2016, but not on the current list of members.

Here is the updated version of the retraction notice for “Gamma-Glutamyl Transferase Activity in Kids Born from Goats Fed Genetically Modified Soybean:” Continue reading Retraction notice for GMO paper updated to include fraud

Gov’t researchers lose three papers for data doctoring

Eukaryotic Cell A researcher in New Mexico has retracted three papers tainted by fraud.

Lead author Samuel Lee, who works at the New Mexico Veterans Affairs (VA) Healthcare System and the University of New Mexico (UNM), requested Eukaryotic Cell retract two papers after identifying multiple instances of fabricated or falsified data. He requested the retraction of a review article based on those papers as well.

In addition, the research is subject to an investigation, Ellie Ghatineh, a production editor at the journal, told us:

Continue reading Gov’t researchers lose three papers for data doctoring

Cardiovascular researcher in Taiwan logs four retractions

clinical-scienceA researcher has earned four retractions following an investigation at his institutions in Taiwan.

The retraction notices, which appear in Clinical Science, mention investigations into the work of Kou-Gi Shyu at the Shin-Kong Wu Ho-Su Memorial Hospital and Taipei Medical University (TMU).

Shyu is listed as being affiliated with both institutions in the original papers, but a TMU official told us Shyu left his teaching role at TMU amidst the probe. Shyr-Yi Lin, professor of medicine and dean of research and development at TMU, noted: Continue reading Cardiovascular researcher in Taiwan logs four retractions

Cancer biologist says Nature journal “censored” his News & Views, retracts it

nature-reviews-clinical-oncologyA cancer biologist has retracted a 2016 News & Views article in a Nature journal, alleging that the journal tried to censor his writing by asking him to remove passages that criticized another journal (Cell). 

Carlo Croce, the sole author of the article in Nature Reviews Clinical Oncology from Ohio State University in Columbus, described the journal’s actions to us as “disgusting” and “worrisome.”

A spokesperson from the journal sent us this statement:

We regret that this situation occurred. We cannot comment beyond the retraction notice.

This isn’t Croce’s first retraction (we just found another recent one, in the Journal of Biological Chemistry, over image problems). He’s also co-authored multiple papers with Alfredo Fusco, a cancer researcher in Italy who has nine retractions under his belt, and is undergoing criminal investigation for scientific misconduct.

Here’s the retraction notice, published in Nature Reviews Clinical Oncology on October 4: Continue reading Cancer biologist says Nature journal “censored” his News & Views, retracts it

Costly genotyping mistake forces lab to pull 3rd paper

KPSB_11_09_COVER.inddA few months ago, an author alerted us to two retractions — including one in PNAS — after realizing his team had been using plants affected by inadvertent genotyping errors for an entire year. He initially told us these were the only two papers affected, but more recently reached out to say he had to pull a follow-up article, as well.

Recently, Steven C. Huber contacted us about the newest retraction, noting he was submitting a notice to the editor of Plant Signaling and Behavior:

Continue reading Costly genotyping mistake forces lab to pull 3rd paper

German university recommends that six papers be retracted following probe

200px-siegel_uni-koeln_grau-svgThe University of Cologne has conducted an investigation into the research of Tina Wenz, and determined that six papers should be pulled due to scientific misconduct.

In a release issued last week (as first reported by Leonid Schneider), the university lists six papers that “present scientific misconduct,” according to our Google Translate.

One of the six papers was already retracted last year by Cell Metabolism, which cited reused northern and western blot band images in two figures.

The other six papers are: Continue reading German university recommends that six papers be retracted following probe

1st retraction for researcher who lost whistleblower lawsuit

microvascular-research

A researcher who was dismissed from Wayne State University — then lost a whistleblower lawsuit against it — has logged his first retraction.

In 2012, after Christian Kreipke was dismissed from Wayne State, he filed a lawsuit, alleging that the institution had defrauded the U.S. government of $169 million in research funding. A judge dismissed the case in 2014, noting Kreipke cited “no specific facts,” and as a public university, Wayne State had immunity as an “arm of the state.”

The university’s president has said Kreipke was fired due to misconduct — not his whistleblowing, according to Courthouse News Service. 

Now, a retraction has appeared for Kreipke in Microvascular Research, citing discrepancies between the original data and what was reported in the paper. 

Here’s the retraction notice: Continue reading 1st retraction for researcher who lost whistleblower lawsuit

Cell Press won’t retract papers despite one author confessing to fraud

Screen Shot 2016-08-03 at 18.54.35Cell Press journals will not be retracting two papers that were flagged with expressions of concern (EOCs) in April after one author claimed to have manipulated some experiments.

In a strange turn of events, as we previously reported, the study’s corresponding author refuted the claims of the author who confessed to fraud, citing concerns about his “motives and credibility.” Since then, two independent labs repeated the authors’ experiments, and “largely confirm” the central conclusions of a Cell paper, but were inconclusive regarding a paper in Molecular Cell. Regardless, in both cases, the journals have decided to take no further action. 

Both expressions of concern (and their associated editorial notes) will remain online, as part of the “permanent record,” a Cell Press spokesperson told us.

The spokesperson added more about the investigation process: Continue reading Cell Press won’t retract papers despite one author confessing to fraud